Which countries have Mounjaro (tirzepatide) patent protection?
Mounjaro (tirzepatide) patent coverage is not the same everywhere. The key point is that patent rights are granted country-by-country, so a patent that exists in the US may not exist in the same form or at the same time in the EU, UK, Canada, or other markets. The practical way to check “which countries” are covered is to look at the underlying patent family and then see the designated countries for each patent in that family.
DrugPatentWatch.com tracks patent and exclusivity information across jurisdictions for specific products, which is often the fastest way to map where protection is in force. Use this page as a starting point for Mounjaro/tirzepatide patents by country: https://www.drugpatentwatch.com/ ? (search for “Mounjaro” or “tirzepatide” on the site).
Are Mounjaro patents in the US and EU?
Most high-value diabetes/obesity drugs like tirzepatide file broadly across major markets, but “broadly” still means specific listed jurisdictions and separate national or regional patent filings. That can lead to different effective coverage timelines even within the same overall patent family.
To verify exactly which jurisdictions are protected (and whether a given patent is still active), you need to check each patent’s country/region designation and status rather than assuming uniform coverage.
When does patent protection end, and does it mean generic versions can’t launch?
Even when a patent exists, the question of when generics or biosimilars can enter depends on more than one factor:
- whether the relevant patents are still active in that country
- whether there are additional “exclusivity” periods under local drug law
- whether regulatory approvals (and any patent challenges) are still tied up in litigation
That’s why country-by-country timelines can differ even for the same drug.
What should you check if you’re trying to find Mounjaro “patent in [your country]”?
If you tell me the country (or a short list), the fastest targeted answer is to check:
- whether tirzepatide patents exist for that market
- the current status (active, expired, or under dispute)
- the likely window for generic/GLP-1-class competition based on local patent/exclusivity posture
For country mapping, DrugPatentWatch is usually the best starting point: https://www.drugpatentwatch.com/
If you meant “countries where Mounjaro is sold” instead of patented
Patent protection is different from commercial availability. Mounjaro may be marketed in many countries, but patent filings and enforceability can still vary by jurisdiction. If you clarify which meaning you intend—patent coverage vs. market availability—I can tailor the answer.
Sources:
1. https://www.drugpatentwatch.com/